HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Hideyuki Tamai Selected Research

Pepsinogen A (Pepsinogen)

3/2014Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
12/2012Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis.
4/2011Assessment of gastroesophageal reflux disease by serodiagnosis of Helicobacter pylori-related chronic gastritis stage.
3/2010Preventive effects of etodolac, a selective cyclooxygenase-2 inhibitor, on cancer development in extensive metaplastic gastritis, a Helicobacter pylori-negative precancerous lesion.
12/2009Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels.
8/2008Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels.
4/2008Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males.
1/2007Serum pepsinogen and gastric cancer screening.
10/2005Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography.
3/2004Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Hideyuki Tamai Research Topics

Disease

18Neoplasms (Cancer)
02/2015 - 08/2005
8Stomach Neoplasms (Stomach Cancer)
12/2012 - 08/2005
6Fibrosis (Cirrhosis)
01/2015 - 01/2011
5Hepatocellular Carcinoma (Hepatoma)
01/2015 - 01/2011
5Gastritis
03/2014 - 03/2010
4Inflammation
10/2013 - 08/2005
3Atrophy
03/2014 - 04/2008
2Thrombocytopenia (Thrombopenia)
01/2015 - 02/2011
2Esophageal and Gastric Varices (Esophageal Varices)
01/2015 - 03/2014
2Hepatitis C
07/2014 - 02/2011
2Stomach Ulcer (Gastric Ulcer)
01/2014 - 07/2012
2Atrophic Gastritis
04/2008 - 01/2007
1Thrombosis (Thrombus)
01/2014
1Airway Obstruction (Choking)
09/2013
1Pancreatic Neoplasms (Pancreatic Cancer)
08/2013
1Hemorrhage
07/2012
1False Aneurysm (Pseudoaneurysm)
07/2012
1Body Weight (Weight, Body)
03/2012
1Gastroesophageal Reflux (GERD)
04/2011
1Hypersplenism (Anemia, Splenic)
02/2011
1Ischemia
01/2011
1Acalculous Cholecystitis
01/2011
1Neoplasm Metastasis (Metastasis)
01/2011
1Glucagonoma
01/2011
1Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2011
1Hypercalcemia (Milk Alkali Syndrome)
01/2011
1Cholecystitis
01/2011
1Achlorhydria (Hypochlorhydria)
04/2009
1Portal Hypertension
01/2009
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2009
1Chronic Hepatitis C
09/2007
1Cysts
01/2006
1Obstructive Jaundice (Cholestatic Jaundice)
01/2006
1Metaplasia
08/2005
1Infection
03/2004

Drug/Important Bio-Agent (IBA)

10Pepsinogen A (Pepsinogen)IBA
03/2014 - 03/2004
6InterferonsIBA
01/2015 - 09/2007
4Ribavirin (Virazole)FDA LinkGeneric
07/2014 - 09/2007
3alpha-Fetoproteins (AFP)IBA
01/2014 - 09/2009
3Biological Markers (Surrogate Marker)IBA
10/2013 - 06/2011
2EnbucrilateIBA
03/2014 - 07/2012
2InterleukinsIBA
01/2014 - 07/2011
2Proton Pumps (Proton Pump)IBA
01/2014 - 04/2009
2RNA (Ribonucleic Acid)IBA
01/2014 - 09/2007
2Biological Tumor Markers (Tumor Markers)IBA
08/2011 - 09/2009
2Etodolac (Lodine)FDA LinkGeneric
03/2010 - 08/2005
2AntibodiesIBA
08/2008 - 03/2004
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2015
1AntigensIBA
02/2014
1lansoprazole (Prevacid)FDA LinkGeneric
01/2014
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
01/2014
1Hyaluronic Acid (Hyaluronan)IBA
01/2014
1Guanosine Triphosphate (GTP)IBA
01/2014
1Am 80 (tamibarotene)IBA
01/2014
1glucuronyl glucosamine glycan sulfate (Vessel)IBA
08/2013
1lentil lectinIBA
12/2012
1Chemotactic FactorsIBA
07/2012
1Methylnitronitrosoguanidine (MNNG)IBA
07/2012
1rebamipideIBA
07/2012
1Ethiodized Oil (Ethiodol)FDA Link
07/2012
1Diazepam (Valium)FDA LinkGeneric
03/2012
1acarboxyprothrombin (PIVKA)IBA
08/2011
1Interleukin-18 (Interleukin 18)IBA
07/2011
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2011
1Interleukin-12 (IL 12)IBA
07/2011
1Gadolinium DTPA (Magnevist)FDA Link
06/2011
1sorafenib (BAY 43-9006)FDA Link
01/2011
1Parathyroid Hormone-Related ProteinIBA
01/2011
1HormonesIBA
01/2011
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
03/2010
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2010
1AmmoniaIBA
01/2009
1Pepsinogen CIBA
04/2008
1SHU 508 (Levovist)IBA
03/2006
1EnzymesIBA
01/2006
1monoethanolamine oleateIBA
01/2006
1BariumIBA
10/2005

Therapy/Procedure

2Splenectomy
01/2015 - 02/2011
2Chemoprevention
03/2010 - 08/2005
1Catheters
03/2014
1Suction (Suction Drainage)
09/2013
1Drug Therapy (Chemotherapy)
08/2013
1Pancreatectomy
01/2011
1Sclerotherapy
01/2006